DBD (Diebold Nixdorf Incorporated) may reap gains as insiders became active recently

0
1

Diebold Nixdorf Incorporated’s filing revealed that its Director COSTELLO ELLEN acquired Company’s shares for reported $39480.0 on May 17. In the deal valued at $3.29 per share,12,000 shares were bought. As a result of this transaction, COSTELLO ELLEN now holds 166,283 shares worth roughly $ 0.35 million.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored


Then, BESANKO BRUCE H bought 7,152 shares, generating $25,032 in total proceeds. Upon buying the shares at $3.50, the Director now owns 100,726 shares.

Before that, RUTHERFORD JEFFREY L bought 14,784 shares. Diebold Nixdorf Incorporated shares valued at $50,295 were divested by the EVP and CFO at a price of $3.40 per share. As a result of the transaction, RUTHERFORD JEFFREY L now holds 447,340 shares, worth roughly $0.94 million.

DA Davidson downgraded its Diebold Nixdorf Incorporated [DBD] rating to a Neutral from a a Buy in a research note published on Friday, October 24, 2022; the price target was decreased to $3 from $5. PT values the company’s stock at a premium of 30.0 to its Friday closing price. A number of analysts have revised their coverage, including JP Morgan’s analysts, who decreased its forecast for the stock in mid August from “a Neutral” to “an Underweight”. Wedbush also remained covering DBD and has increased its forecast on July 08, 2022 with a “an Outperform” recommendation from previously “Neutral” rating. JP Morgan revised its rating on May 10, 2022. It rated DBD as “a Neutral” which previously was an “an Overweight”.

Price Performance Review of DBD

On Friday, Diebold Nixdorf Incorporated [NYSE:DBD] saw its stock jump 5.00% to $2.10. On the same session, the stock had its day’s lowest price of $1.99, but rose to a high of $2.10. Over the last five days, the stock has lost -10.26%. Diebold Nixdorf Incorporated shares have fallen nearly -76.80% since the year began. Nevertheless, the stocks have fallen -76.82% over the past one year. While a 52-week high of $11.00 was reached on 01/14/22, a 52-week low of $1.91 was recorded on 10/24/22. SMA at 50 days reached $2.78, while 200 days put it at $4.52. A total of 0.97 million shares were traded, compared to the trading of 1.16 million shares in the previous session.

Levels Of Support And Resistance For DBD Stock

The 24-hour chart illustrates a support level at 2.03, which if violated will result in even more drops to 1.95. On the upside, there is a resistance level at 2.14. A further resistance level may holdings at 2.17. The Relative Strength Index (RSI) on the 14-day chart is 38.67, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.17, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 84.39%. Stochastics %K at 17.02% indicates the stock is a buying.

How much short interest is there in Diebold Nixdorf Incorporated?

A steep rise in short interest was recorded in Diebold Nixdorf Incorporated stocks on Jul 14, 2022, dropping by 10000.0 shares to a total of 10.87 million shares. Yahoo Finance data shows the prior-month short interest on Jun 14, 2022 was 10.88 million shares. There was a decline of -0.09%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 16.40% of the overall stock float, the days-to-cover ratio (short ratio) fell to 4.97.

Diebold Nixdorf Incorporated [DBD] – Who Are The Largest Shareholders?

In filings from BlackRock Fund Advisors, it is revealed that the company now owns 10,407,808 shares, or roughly 13.16% of the outstanding DBD shares. In other words, the investor’s shares have risen by 142,601 from its previous 13-F filing of 10265207.0. Additionally, The Vanguard Group, Inc. decreased -31.53% of its stake after which the total value it holdings stand at $12,706,585, while GAMCO Asset Management, Inc. reduced -15.20% of its stake to hold $8.03 million in the firm. Over the last quarter, Beach Point Capital Management LP sold -732,994 shares of Diebold Nixdorf Incorporated, while D. E. Shaw & Co. LP sold 340,778 shares. At present, SSgA Funds Management, Inc. is holding 2,589,252 shares valued at $6.32 million. Hotchkis & Wiley Capital Manageme owned 2,554,260 shares of the company at the time of its most recent 13F filing, worth $6.23 million.

According to FactSet, Diebold Nixdorf Incorporated’s share price will average $4.00 in the next year, based on opinions of analysts polled by the firm. This is up nearly 100.0 percent from its previous closing price of $2.00. Analysts expect Diebold Nixdorf Incorporated stock to reach the higher price of $5.00, while the lowest price estimate is $3.00. However, 5 analysts have rated DBD stock as a Hold in their predictions for 2022. The most recent change occurred on June 21, 2021 when Wedbush began covering the stock and recommended ‘”a Neutral”‘ rating along with a $14 price target.

LEAVE A REPLY

Please enter your comment!
Please enter your name here